Cargando…
Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial
Ovarian hyperstimulation syndrome (OHSS) during ovarian stimulation is a current challenge for patients with polycystic ovarian syndrome (PCOS). Our previous studies indicated that progestin can prevent premature luteinizing hormone (LH) surge or moderate/severe OHSS in the general subfertile popula...
Autores principales: | Wang, Yun, Chen, Qiuju, Wang, NingLing, Chen, Hong, Lyu, Qifeng, Kuang, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782886/ https://www.ncbi.nlm.nih.gov/pubmed/26945402 http://dx.doi.org/10.1097/MD.0000000000002939 |
Ejemplares similares
-
Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2017) -
Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles
por: Sun, Lihua, et al.
Publicado: (2018) -
The role of combining medroxyprogesterone 17-acetate with human menopausal gonadotropin in mouse ovarian follicular development
por: Wen, Xiaowei, et al.
Publicado: (2018) -
Elevated progesterone on the trigger day does not impair the outcome of Human Menotrophins Gonadotrophin and Medroxyprogesterone acetate treatment cycles
por: Lu, Xuefeng, et al.
Publicado: (2016) -
Efficacy of clomifene citrate for the treatment of patients with polycystic ovary syndrome: A protocol of systematic review
por: Han, Qin-wei, et al.
Publicado: (2020)